Charles Schwab Investment Management Inc Idera Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.01 - $1.58 $18,635 - $29,152	-18,451 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.23 - $5.98 $22,694 - $110,336	18,451 New	18,451 $24,000
Q2 2019 Aug 09, 2019	SELL	$2.37 - $3.97 $100,691 - $168,669	-42,486 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$5.53 - $11.36 $234,947 - $482,640	42,486 New	42,486 $379,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.